Eaton Vance Worldwide Health Sciences does not have any pronounced advantages over its competition at this point in time, and all its share classes earn Morningstar Analyst Ratings of Neutral.
Eaton Vance Worldwide Health Sci A ETHSX
NAV / 1-Day Return
13.14
/
1.13
%
Total Assets
1.2 Bil
Adj. Expense Ratio
Adjusted Expense Ratio excludes certain variable investment-related expenses, such as interest from borrowings and dividends on borrowed securities, allowing for more consistent cost comparisons across funds.
1.160%
Expense Ratio
1.160%
Fee Level
Below Average
Longest Manager Tenure
5.56
years
Category
Health
Investment Style
Large BlendMin. Initial Investment
1,000
Status
Open
TTM Yield
0.22%
Turnover
32%
Premium
Morningstar’s Analysis
The Morningstar Analysis section contains a thorough evaluation of an investment’s merits and drawbacks and often discusses the most important or decisive factors leading to the fund’s overall rating.
The Morningstar Analysis section contains a thorough evaluation of an investment’s merits and drawbacks and often discusses the most important or decisive factors leading to the fund’s overall rating.
Will ETHSX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
Process Pillar
The Process Pillar is our assessment of how sensible, clearly defined, and repeatable ETHSX’s performance objective and investment process is for both security selection and portfolio construction.
People Pillar
The People Pillar is our evaluation of the ETHSX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of ETHSX’s parent organization’s priorities and whether they’re in line with investors’ interests.
Not a standout in its category.
